Reward Processing in Mental Illness

NCT ID: NCT03068793

Last Updated: 2019-07-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

80 participants

Study Classification

OBSERVATIONAL

Study Start Date

2013-10-01

Study Completion Date

2019-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to examine the nature of reward processing dysfunctions in schizophrenia using neuroimaging techniques that capture in vivo brain functioning, such as EEG and fMRI.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This experiment takes place over the course of two or three days. On each visit day, the experiment will involve a brief interview session, electroencephalography (EEG) recording,and/or a magnetic resonance imaging (MRI).

Screening tests or procedures include:

* If you are female of child bearing potential, you must complete a urine pregnancy test for the MRI procedure
* You will be asked a series of questions about your mental health and your background

If the screening exam shows that you can be in the main part of the study and you choose to continue, these are the tests and procedures that you would complete on one or two test days:

* EEG recording: In this procedure, the researcher will assess your brain function while you perform simple computer-based tasks. The computer tasks involve presentation of pictures to which you respond by pressing a button. You will be given clear instructions and a chance to practice before each task. While you are performing these tasks, we will record the weak electrical signals produced by your brain, or "brain waves", using a technique called electroencephalography (EEG).

* In order to record your EEG, sensors (small plastic discs) will be attached to specific locations on your scalp. Your scalp will be gently scrubbed before the sensors are attached. The sensors are held in place on your scalp using a nylon cap that fits snugly on your head. Sensors will also be attached above and below your eyes and will record your eye movements. It will take approximately one hour to attach the sensors. The entire EEG will take approximately 2 hours.
* Before you take part in the EEG session, please make sure to wash your hair and scalp. Do not use conditioner or a 2-in-1 shampoo/conditioner. Your hair should be dry before your arrival. We ask this in order to make the set-up process go more smoothly.
* MRI: In the fMRI procedure, we will use a magnet to measure blood flow to your brain while you do different cognitive tasks. You will be asked to lie down on a platform that can be slid into the middle of the magnet. A plastic MRI imaging coil will be placed around your head. You will not come into contact with the coil during the experiment. Foam pads will be placed around your head to limit head movement during the experiment. We will then slide you into the magnet. At different points during the experiment, you will be asked to do the same tasks you did in the training session prior to the scan. During the scan, you will be asked to either lie still and rest, or do some tasks similar to those you completed during your EEG. The entire MRI will take approximately two hours.

* If the researchers feel as though the quality of data collected by the scanner can be improved, you may be asked to return for an additional scan session.
* Brief interview session: There will be a series of questions about your education, smoking status, and economic background. You will also be given a list of words to read to the researcher. If you are a patient diagnosed with one of the above-mentioned psychiatric disorders, you will be asked to participate in an additional interview, lasting about one hour, focusing on how you have been feeling recently.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Early-onset Schizophrenia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients with Recent Onset Schizophrenia

Individuals who have been diagnosed with Schizophrenia, Schizoaffective Disorder, or Schizophreniform Disorder within the past five years and meet our research criteria for symptoms indicative of these diseases within the past five years.

Electroencephalography (EEG) and Magnetic Resonance Imaging (MRI)

Intervention Type DIAGNOSTIC_TEST

We will use these techniques combined with tests of reward anticipation and clinical interviews to explore connections between these measures and activity in the brain in patients with a diagnosis of schizophrenia, major depressive disorder, gambling disorder, or post traumatic stress disorder and healthy controls.

Patients with Major Depressive Disorder

Individuals who have been diagnosed with Major Depressive Disorder within the past five years and meet our research criteria for symptoms indicative of this disease within the past five years.

Electroencephalography (EEG) and Magnetic Resonance Imaging (MRI)

Intervention Type DIAGNOSTIC_TEST

We will use these techniques combined with tests of reward anticipation and clinical interviews to explore connections between these measures and activity in the brain in patients with a diagnosis of schizophrenia, major depressive disorder, gambling disorder, or post traumatic stress disorder and healthy controls.

Patients with Gambling Disorder

Individuals who have been diagnosed with Gambling Disorder within the past five years and meet our research criteria for symptoms indicative of this disease within the past five years.

Electroencephalography (EEG) and Magnetic Resonance Imaging (MRI)

Intervention Type DIAGNOSTIC_TEST

We will use these techniques combined with tests of reward anticipation and clinical interviews to explore connections between these measures and activity in the brain in patients with a diagnosis of schizophrenia, major depressive disorder, gambling disorder, or post traumatic stress disorder and healthy controls.

Patients with Post Traumatic Stress Disorder

Individuals who have been diagnosed with Post Traumatic Stress Disorder within the past five years and meet our research criteria for symptoms indicative of this disease within the past five years.

Electroencephalography (EEG) and Magnetic Resonance Imaging (MRI)

Intervention Type DIAGNOSTIC_TEST

We will use these techniques combined with tests of reward anticipation and clinical interviews to explore connections between these measures and activity in the brain in patients with a diagnosis of schizophrenia, major depressive disorder, gambling disorder, or post traumatic stress disorder and healthy controls.

Healthy Controls

Individuals who have not met criteria for a psychiatric, mood, or gambling disorder within their lifetime according to our research criteria for symptoms indicative of a psychiatric, mood, or gambling disorder.

Electroencephalography (EEG) and Magnetic Resonance Imaging (MRI)

Intervention Type DIAGNOSTIC_TEST

We will use these techniques combined with tests of reward anticipation and clinical interviews to explore connections between these measures and activity in the brain in patients with a diagnosis of schizophrenia, major depressive disorder, gambling disorder, or post traumatic stress disorder and healthy controls.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Electroencephalography (EEG) and Magnetic Resonance Imaging (MRI)

We will use these techniques combined with tests of reward anticipation and clinical interviews to explore connections between these measures and activity in the brain in patients with a diagnosis of schizophrenia, major depressive disorder, gambling disorder, or post traumatic stress disorder and healthy controls.

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* The subject population will include 18 to 30 year old participants of any gender, race, and ethnicity. All subjects will be able to speak and understand English.

Schizophrenia subjects:

1\. Patients must be diagnosed with DSM-IV schizophrenia, schizophreniform, or schizoaffective disorder based on a SCID-P interview.

Depression subjects:

1\. Patients must be diagnosed with DSM-V Major Depressive Disorder based on a SCID-P interview.

Post Traumatic Stress Disorder subjects:

1\. Patients must be diagnosed with DSM-V Post Traumatic Stress Disorder based on a SCID-P interview.

Gambling Disorder subjects:

1\. Patients must be diagnosed with DSM-V Gambling Disorder based on a SCID-P interview.

Comparison subjects:

1\. Control participants must not have past or present Axis I diagnosis as determined by the SCID-NP.

Exclusion Criteria

* All subjects:

1. A hearing deficit greater than 40dB in both ears detected during the hearing test
2. Substance dependence, as per clinical judgment, in the past 1 year (except caffeine and nicotine)
3. A history of significant medical/neurological disease such as cardiac, thyroid, renal, hepatic or neurological
4. History of head injury with loss of consciousness greater than 15 minutes
5. Any other condition or medication, which in the opinion of the investigator would preclude participation in the study.
6. Non-English speaking.

Comparison subjects:

1\. Any first-degree relative with schizophrenia or bipolar disorder.
Minimum Eligible Age

18 Years

Maximum Eligible Age

30 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Susanna Fryer

FED

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Susanna Fryer

Assistant Professor in Residence

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Susanna Fryer, PhD

Role: PRINCIPAL_INVESTIGATOR

San Francisco VA Medical Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

San Francisco VA Medical Center

San Francisco, California, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Fenton WS, McGlashan TH. Natural history of schizophrenia subtypes. II. Positive and negative symptoms and long-term course. Arch Gen Psychiatry. 1991 Nov;48(11):978-86. doi: 10.1001/archpsyc.1991.01810350018003.

Reference Type BACKGROUND
PMID: 1747021 (View on PubMed)

Bleuler, E. Dementia Praecox or the Group of Schizophrenias. (1911) (International Universities Press, New York, NY, Translated by J. Zinkin, 1950).

Reference Type BACKGROUND

Milev P, Ho BC, Arndt S, Andreasen NC. Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up. Am J Psychiatry. 2005 Mar;162(3):495-506. doi: 10.1176/appi.ajp.162.3.495.

Reference Type BACKGROUND
PMID: 15741466 (View on PubMed)

Rabinowitz J, Levine SZ, Garibaldi G, Bugarski-Kirola D, Berardo CG, Kapur S. Negative symptoms have greater impact on functioning than positive symptoms in schizophrenia: analysis of CATIE data. Schizophr Res. 2012 May;137(1-3):147-50. doi: 10.1016/j.schres.2012.01.015. Epub 2012 Feb 6.

Reference Type BACKGROUND
PMID: 22316568 (View on PubMed)

Kirkpatrick B, Fenton WS, Carpenter WT Jr, Marder SR. The NIMH-MATRICS consensus statement on negative symptoms. Schizophr Bull. 2006 Apr;32(2):214-9. doi: 10.1093/schbul/sbj053. Epub 2006 Feb 15. No abstract available.

Reference Type BACKGROUND
PMID: 16481659 (View on PubMed)

Gold JM, Waltz JA, Matveeva TM, Kasanova Z, Strauss GP, Herbener ES, Collins AG, Frank MJ. Negative symptoms and the failure to represent the expected reward value of actions: behavioral and computational modeling evidence. Arch Gen Psychiatry. 2012 Feb;69(2):129-38. doi: 10.1001/archgenpsychiatry.2011.1269.

Reference Type BACKGROUND
PMID: 22310503 (View on PubMed)

Gold JM, Waltz JA, Prentice KJ, Morris SE, Heerey EA. Reward processing in schizophrenia: a deficit in the representation of value. Schizophr Bull. 2008 Sep;34(5):835-47. doi: 10.1093/schbul/sbn068. Epub 2008 Jun 30.

Reference Type BACKGROUND
PMID: 18591195 (View on PubMed)

Heinz A, Schlagenhauf F. Dopaminergic dysfunction in schizophrenia: salience attribution revisited. Schizophr Bull. 2010 May;36(3):472-85. doi: 10.1093/schbul/sbq031. Epub 2010 May 7.

Reference Type BACKGROUND
PMID: 20453041 (View on PubMed)

Waltz JA, Frank MJ, Robinson BM, Gold JM. Selective reinforcement learning deficits in schizophrenia support predictions from computational models of striatal-cortical dysfunction. Biol Psychiatry. 2007 Oct 1;62(7):756-64. doi: 10.1016/j.biopsych.2006.09.042. Epub 2007 Feb 14.

Reference Type BACKGROUND
PMID: 17300757 (View on PubMed)

Barch DM, Dowd EC. Goal representations and motivational drive in schizophrenia: the role of prefrontal-striatal interactions. Schizophr Bull. 2010 Sep;36(5):919-34. doi: 10.1093/schbul/sbq068. Epub 2010 Jun 21.

Reference Type BACKGROUND
PMID: 20566491 (View on PubMed)

Haber SN, Knutson B. The reward circuit: linking primate anatomy and human imaging. Neuropsychopharmacology. 2010 Jan;35(1):4-26. doi: 10.1038/npp.2009.129.

Reference Type BACKGROUND
PMID: 19812543 (View on PubMed)

Maldjian JA, Laurienti PJ, Kraft RA, Burdette JH. An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. Neuroimage. 2003 Jul;19(3):1233-9. doi: 10.1016/s1053-8119(03)00169-1.

Reference Type BACKGROUND
PMID: 12880848 (View on PubMed)

Schultz W. Behavioral theories and the neurophysiology of reward. Annu Rev Psychol. 2006;57:87-115. doi: 10.1146/annurev.psych.56.091103.070229.

Reference Type BACKGROUND
PMID: 16318590 (View on PubMed)

Schultz W, Dayan P, Montague PR. A neural substrate of prediction and reward. Science. 1997 Mar 14;275(5306):1593-9. doi: 10.1126/science.275.5306.1593.

Reference Type BACKGROUND
PMID: 9054347 (View on PubMed)

Berridge KC. The debate over dopamine's role in reward: the case for incentive salience. Psychopharmacology (Berl). 2007 Apr;191(3):391-431. doi: 10.1007/s00213-006-0578-x. Epub 2006 Oct 27.

Reference Type BACKGROUND
PMID: 17072591 (View on PubMed)

Miller R. Schizophrenic psychology, associative learning and the role of forebrain dopamine. Med Hypotheses. 1976 Sep-Oct;2(5):203-11. doi: 10.1016/0306-9877(76)90040-2.

Reference Type BACKGROUND
PMID: 9558 (View on PubMed)

Stein L, Wise CD. Possible etiology of schizophrenia: progressive damage to the noradrenergic reward system by 6-hydroxydopamine. Science. 1971 Mar 12;171(3975):1032-6. doi: 10.1126/science.171.3975.1032.

Reference Type BACKGROUND
PMID: 5100789 (View on PubMed)

Kapur S. Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. Am J Psychiatry. 2003 Jan;160(1):13-23. doi: 10.1176/appi.ajp.160.1.13.

Reference Type BACKGROUND
PMID: 12505794 (View on PubMed)

Bromberg-Martin ES, Matsumoto M, Hikosaka O. Dopamine in motivational control: rewarding, aversive, and alerting. Neuron. 2010 Dec 9;68(5):815-34. doi: 10.1016/j.neuron.2010.11.022.

Reference Type BACKGROUND
PMID: 21144997 (View on PubMed)

Esslinger C, Englisch S, Inta D, Rausch F, Schirmbeck F, Mier D, Kirsch P, Meyer-Lindenberg A, Zink M. Ventral striatal activation during attribution of stimulus saliency and reward anticipation is correlated in unmedicated first episode schizophrenia patients. Schizophr Res. 2012 Sep;140(1-3):114-21. doi: 10.1016/j.schres.2012.06.025. Epub 2012 Jul 10.

Reference Type BACKGROUND
PMID: 22784688 (View on PubMed)

Juckel G, Schlagenhauf F, Koslowski M, Wustenberg T, Villringer A, Knutson B, Wrase J, Heinz A. Dysfunction of ventral striatal reward prediction in schizophrenia. Neuroimage. 2006 Jan 15;29(2):409-16. doi: 10.1016/j.neuroimage.2005.07.051. Epub 2005 Sep 1.

Reference Type BACKGROUND
PMID: 16139525 (View on PubMed)

Nielsen MO, Rostrup E, Wulff S, Bak N, Lublin H, Kapur S, Glenthoj B. Alterations of the brain reward system in antipsychotic naive schizophrenia patients. Biol Psychiatry. 2012 May 15;71(10):898-905. doi: 10.1016/j.biopsych.2012.02.007. Epub 2012 Mar 13.

Reference Type BACKGROUND
PMID: 22418013 (View on PubMed)

Schlagenhauf F, Juckel G, Koslowski M, Kahnt T, Knutson B, Dembler T, Kienast T, Gallinat J, Wrase J, Heinz A. Reward system activation in schizophrenic patients switched from typical neuroleptics to olanzapine. Psychopharmacology (Berl). 2008 Mar;196(4):673-84. doi: 10.1007/s00213-007-1016-4. Epub 2007 Dec 21.

Reference Type BACKGROUND
PMID: 18097655 (View on PubMed)

Schlagenhauf F, Sterzer P, Schmack K, Ballmaier M, Rapp M, Wrase J, Juckel G, Gallinat J, Heinz A. Reward feedback alterations in unmedicated schizophrenia patients: relevance for delusions. Biol Psychiatry. 2009 Jun 15;65(12):1032-9. doi: 10.1016/j.biopsych.2008.12.016. Epub 2009 Feb 5.

Reference Type BACKGROUND
PMID: 19195646 (View on PubMed)

Dowd EC, Barch DM. Pavlovian reward prediction and receipt in schizophrenia: relationship to anhedonia. PLoS One. 2012;7(5):e35622. doi: 10.1371/journal.pone.0035622. Epub 2012 May 4.

Reference Type BACKGROUND
PMID: 22574121 (View on PubMed)

Simon JJ, Biller A, Walther S, Roesch-Ely D, Stippich C, Weisbrod M, Kaiser S. Neural correlates of reward processing in schizophrenia--relationship to apathy and depression. Schizophr Res. 2010 May;118(1-3):154-61. doi: 10.1016/j.schres.2009.11.007. Epub 2009 Dec 16.

Reference Type BACKGROUND
PMID: 20005675 (View on PubMed)

Waltz JA, Schweitzer JB, Ross TJ, Kurup PK, Salmeron BJ, Rose EJ, Gold JM, Stein EA. Abnormal responses to monetary outcomes in cortex, but not in the basal ganglia, in schizophrenia. Neuropsychopharmacology. 2010 Nov;35(12):2427-39. doi: 10.1038/npp.2010.126. Epub 2010 Aug 18.

Reference Type BACKGROUND
PMID: 20720534 (View on PubMed)

Knutson B, Adams CM, Fong GW, Hommer D. Anticipation of increasing monetary reward selectively recruits nucleus accumbens. J Neurosci. 2001 Aug 15;21(16):RC159. doi: 10.1523/JNEUROSCI.21-16-j0002.2001.

Reference Type BACKGROUND
PMID: 11459880 (View on PubMed)

Gard DE, Kring AM, Gard MG, Horan WP, Green MF. Anhedonia in schizophrenia: distinctions between anticipatory and consummatory pleasure. Schizophr Res. 2007 Jul;93(1-3):253-60. doi: 10.1016/j.schres.2007.03.008. Epub 2007 May 9.

Reference Type BACKGROUND
PMID: 17490858 (View on PubMed)

Horan WP, Wynn JK, Kring AM, Simons RF, Green MF. Electrophysiological correlates of emotional responding in schizophrenia. J Abnorm Psychol. 2010 Feb;119(1):18-30. doi: 10.1037/a0017510.

Reference Type BACKGROUND
PMID: 20141239 (View on PubMed)

Kring AM, Moran EK. Emotional response deficits in schizophrenia: insights from affective science. Schizophr Bull. 2008 Sep;34(5):819-34. doi: 10.1093/schbul/sbn071. Epub 2008 Jun 25.

Reference Type BACKGROUND
PMID: 18579556 (View on PubMed)

Koch K, Schachtzabel C, Wagner G, Schikora J, Schultz C, Reichenbach JR, Sauer H, Schlosser RG. Altered activation in association with reward-related trial-and-error learning in patients with schizophrenia. Neuroimage. 2010 Mar;50(1):223-32. doi: 10.1016/j.neuroimage.2009.12.031. Epub 2009 Dec 16.

Reference Type BACKGROUND
PMID: 20006717 (View on PubMed)

Morris RW, Vercammen A, Lenroot R, Moore L, Langton JM, Short B, Kulkarni J, Curtis J, O'Donnell M, Weickert CS, Weickert TW. Disambiguating ventral striatum fMRI-related BOLD signal during reward prediction in schizophrenia. Mol Psychiatry. 2012 Mar;17(3):235, 280-9. doi: 10.1038/mp.2011.75. Epub 2011 Jun 28.

Reference Type BACKGROUND
PMID: 21709684 (View on PubMed)

Murray GK, Corlett PR, Clark L, Pessiglione M, Blackwell AD, Honey G, Jones PB, Bullmore ET, Robbins TW, Fletcher PC. Substantia nigra/ventral tegmental reward prediction error disruption in psychosis. Mol Psychiatry. 2008 Mar;13(3):239, 267-76. doi: 10.1038/sj.mp.4002058. Epub 2007 Aug 7.

Reference Type BACKGROUND
PMID: 17684497 (View on PubMed)

Miltner WH, Braun CH, Coles MG. Event-related brain potentials following incorrect feedback in a time-estimation task: evidence for a "generic" neural system for error detection. J Cogn Neurosci. 1997 Nov;9(6):788-98. doi: 10.1162/jocn.1997.9.6.788.

Reference Type BACKGROUND
PMID: 23964600 (View on PubMed)

Gehring WJ, Willoughby AR. The medial frontal cortex and the rapid processing of monetary gains and losses. Science. 2002 Mar 22;295(5563):2279-82. doi: 10.1126/science.1066893.

Reference Type BACKGROUND
PMID: 11910116 (View on PubMed)

Walsh MM, Anderson JR. Learning from experience: event-related potential correlates of reward processing, neural adaptation, and behavioral choice. Neurosci Biobehav Rev. 2012 Sep;36(8):1870-84. doi: 10.1016/j.neubiorev.2012.05.008. Epub 2012 Jun 7.

Reference Type BACKGROUND
PMID: 22683741 (View on PubMed)

Horan WP, Foti D, Hajcak G, Wynn JK, Green MF. Impaired neural response to internal but not external feedback in schizophrenia. Psychol Med. 2012 Aug;42(8):1637-47. doi: 10.1017/S0033291711002819. Epub 2011 Dec 8.

Reference Type BACKGROUND
PMID: 22152069 (View on PubMed)

Morris SE, Holroyd CB, Mann-Wrobel MC, Gold JM. Dissociation of response and feedback negativity in schizophrenia: electrophysiological and computational evidence for a deficit in the representation of value. Front Hum Neurosci. 2011 Oct 28;5:123. doi: 10.3389/fnhum.2011.00123. eCollection 2011.

Reference Type BACKGROUND
PMID: 22065618 (View on PubMed)

Morris SE, Heerey EA, Gold JM, Holroyd CB. Learning-related changes in brain activity following errors and performance feedback in schizophrenia. Schizophr Res. 2008 Feb;99(1-3):274-85. doi: 10.1016/j.schres.2007.08.027. Epub 2007 Sep 24.

Reference Type BACKGROUND
PMID: 17889510 (View on PubMed)

Roiser JP, Stephan KE, den Ouden HE, Barnes TR, Friston KJ, Joyce EM. Do patients with schizophrenia exhibit aberrant salience? Psychol Med. 2009 Feb;39(2):199-209. doi: 10.1017/S0033291708003863. Epub 2008 Jun 30.

Reference Type BACKGROUND
PMID: 18588739 (View on PubMed)

Chiew KS, Braver TS. Positive affect versus reward: emotional and motivational influences on cognitive control. Front Psychol. 2011 Oct 19;2:279. doi: 10.3389/fpsyg.2011.00279. eCollection 2011.

Reference Type BACKGROUND
PMID: 22022318 (View on PubMed)

Pessoa L. How do emotion and motivation direct executive control? Trends Cogn Sci. 2009 Apr;13(4):160-6. doi: 10.1016/j.tics.2009.01.006. Epub 2009 Mar 13.

Reference Type BACKGROUND
PMID: 19285913 (View on PubMed)

Savine AC, Braver TS. Motivated cognitive control: reward incentives modulate preparatory neural activity during task-switching. J Neurosci. 2010 Aug 4;30(31):10294-305. doi: 10.1523/JNEUROSCI.2052-10.2010.

Reference Type BACKGROUND
PMID: 20685974 (View on PubMed)

Locke HS, Braver TS. Motivational influences on cognitive control: behavior, brain activation, and individual differences. Cogn Affect Behav Neurosci. 2008 Mar;8(1):99-112. doi: 10.3758/cabn.8.1.99.

Reference Type BACKGROUND
PMID: 18405050 (View on PubMed)

Small DM, Gitelman D, Simmons K, Bloise SM, Parrish T, Mesulam MM. Monetary incentives enhance processing in brain regions mediating top-down control of attention. Cereb Cortex. 2005 Dec;15(12):1855-65. doi: 10.1093/cercor/bhi063. Epub 2005 Mar 2.

Reference Type BACKGROUND
PMID: 15746002 (View on PubMed)

Jimura K, Locke HS, Braver TS. Prefrontal cortex mediation of cognitive enhancement in rewarding motivational contexts. Proc Natl Acad Sci U S A. 2010 May 11;107(19):8871-6. doi: 10.1073/pnas.1002007107. Epub 2010 Apr 26.

Reference Type BACKGROUND
PMID: 20421489 (View on PubMed)

Krawczyk DC, Gazzaley A, D'Esposito M. Reward modulation of prefrontal and visual association cortex during an incentive working memory task. Brain Res. 2007 Apr 13;1141:168-77. doi: 10.1016/j.brainres.2007.01.052. Epub 2007 Jan 25.

Reference Type BACKGROUND
PMID: 17320835 (View on PubMed)

Taylor SF, Welsh RC, Wager TD, Phan KL, Fitzgerald KD, Gehring WJ. A functional neuroimaging study of motivation and executive function. Neuroimage. 2004 Mar;21(3):1045-54. doi: 10.1016/j.neuroimage.2003.10.032.

Reference Type BACKGROUND
PMID: 15006672 (View on PubMed)

O'Connor DA, Rossiter S, Yucel M, Lubman DI, Hester R. Successful inhibitory control over an immediate reward is associated with attentional disengagement in visual processing areas. Neuroimage. 2012 Sep;62(3):1841-7. doi: 10.1016/j.neuroimage.2012.05.040. Epub 2012 May 25.

Reference Type BACKGROUND
PMID: 22641143 (View on PubMed)

Egner T, Hirsch J. Cognitive control mechanisms resolve conflict through cortical amplification of task-relevant information. Nat Neurosci. 2005 Dec;8(12):1784-90. doi: 10.1038/nn1594. Epub 2005 Nov 6.

Reference Type BACKGROUND
PMID: 16286928 (View on PubMed)

Watanabe M, Sakagami M. Integration of cognitive and motivational context information in the primate prefrontal cortex. Cereb Cortex. 2007 Sep;17 Suppl 1:i101-9. doi: 10.1093/cercor/bhm067.

Reference Type BACKGROUND
PMID: 17725993 (View on PubMed)

Braver TS, Barch DM, Cohen JD. Cognition and control in schizophrenia: a computational model of dopamine and prefrontal function. Biol Psychiatry. 1999 Aug 1;46(3):312-28. doi: 10.1016/s0006-3223(99)00116-x.

Reference Type BACKGROUND
PMID: 10435197 (View on PubMed)

Cohen JD, Braver TS, Brown JW. Computational perspectives on dopamine function in prefrontal cortex. Curr Opin Neurobiol. 2002 Apr;12(2):223-9. doi: 10.1016/s0959-4388(02)00314-8.

Reference Type BACKGROUND
PMID: 12015241 (View on PubMed)

Fryer SL, Jorgensen KW, Yetter EJ, Daurignac EC, Watson TD, Shanbhag H, Krystal JH, Mathalon DH. Differential brain response to alcohol cue distractors across stages of alcohol dependence. Biol Psychol. 2013 Feb;92(2):282-91. doi: 10.1016/j.biopsycho.2012.10.004. Epub 2012 Nov 3.

Reference Type BACKGROUND
PMID: 23131612 (View on PubMed)

Kriegeskorte N, Lindquist MA, Nichols TE, Poldrack RA, Vul E. Everything you never wanted to know about circular analysis, but were afraid to ask. J Cereb Blood Flow Metab. 2010 Sep;30(9):1551-7. doi: 10.1038/jcbfm.2010.86. Epub 2010 Jun 23.

Reference Type BACKGROUND
PMID: 20571517 (View on PubMed)

First, M., Spitzer, R., Gibbon, M. & Williams, J. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition. (SCID-I/P). (New York State Psychiatric Institute, 2002).

Reference Type BACKGROUND

Horan WP, Kring AM, Gur RE, Reise SP, Blanchard JJ. Development and psychometric validation of the Clinical Assessment Interview for Negative Symptoms (CAINS). Schizophr Res. 2011 Nov;132(2-3):140-5. doi: 10.1016/j.schres.2011.06.030. Epub 2011 Jul 27.

Reference Type BACKGROUND
PMID: 21798716 (View on PubMed)

Kring AM, Gur RE, Blanchard JJ, Horan WP, Reise SP. The Clinical Assessment Interview for Negative Symptoms (CAINS): final development and validation. Am J Psychiatry. 2013 Feb;170(2):165-72. doi: 10.1176/appi.ajp.2012.12010109.

Reference Type BACKGROUND
PMID: 23377637 (View on PubMed)

Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261-76. doi: 10.1093/schbul/13.2.261.

Reference Type BACKGROUND
PMID: 3616518 (View on PubMed)

Hollingshead AB, Redlich FC. Social class and mental illness: a community study. 1958. Am J Public Health. 2007 Oct;97(10):1756-7. doi: 10.2105/ajph.97.10.1756. No abstract available.

Reference Type BACKGROUND
PMID: 17895405 (View on PubMed)

Oldfield RC. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia. 1971 Mar;9(1):97-113. doi: 10.1016/0028-3932(71)90067-4. No abstract available.

Reference Type BACKGROUND
PMID: 5146491 (View on PubMed)

Fagerstrom KO. Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment. Addict Behav. 1978;3(3-4):235-41. doi: 10.1016/0306-4603(78)90024-2. No abstract available.

Reference Type BACKGROUND
PMID: 735910 (View on PubMed)

Wechsler, D. Wechsler Test of Adult Reading., (Psychological Corporation, 2001).

Reference Type BACKGROUND

Weissman, A. The Dysfunctional Attitudes Scale: A validation study., University of Pennsylvania, (1973).

Reference Type BACKGROUND

Carver, C. S. & White, T. L. Behavioral inhibition, behavioral activation, and affective responses to impending reward and punishment: The BIS/BAS Scales. Journal of Personality and Social Psychology 67,319-333 (1994).

Reference Type BACKGROUND

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IK2CX001028

Identifier Type: NIH

Identifier Source: org_study_id

View Link

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Visual Perception in Schizophrenia
NCT06911931 RECRUITING NA